Hyperglycemia, or high blood sugar is a condition in which an excessive amount of glucose circulates in the blood plasma. This is generally a blood sugar level higher than 11.1 mmol/l (200 mg/dl), but symptoms may not start to become noticeable until even higher values such as 15–20 mmol/l (~250–300 mg/dl). Several factors can contribute to hyperglycemia in people with diabetes, including food and physical activity choices, illness, nondiabetes medications, or skipping or not taking enough glucose-lowering medication.Hyperglycemia is the technical term for high blood glucose (blood sugar) .Hyperglycemia can also lead to more serious conditions, including ketoacidosis -- mostly in people with type 1 diabetes -- and hyperglycemic hyperosmolar nonketotic syndrome (HHNS) in people with type 2 diabetes or in people at risk for type 2 diabetes. It's important to treat hyperglycemia, because if left untreated, hyperglycemia can become severe and lead to serious complications requiring emergency care, such as diabetic coma.

OMICS International Organizes 1000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The conference series website will provide you list and details about the conference organize worldwide.

Scope and Importance:

Hyperglycaemia Conference provides the scope for opportunities to learn progressed by international scientists and academicians. Hyperglycaemia Conference offers excessive quality content to suit the diverse professional development of these medicines to treat people all over the globe. It is a perfect platform to discuss the current discoveries and developments in the field of Diabetes and Endocrinology

Hyperglycaemia/ hyperglycemia, or high blood sugar (glucose), is a serious health problem for those with diabetes. Hyperglycemia is the technical term for high blood glucose (blood sugar). High blood glucose happens when the body has too little insulin or when the body can't use insulin properly. In people with diabetes, there are two specific types of hyperglycemia that occur: • Fasting hyperglycemia is defined as a blood sugar greater than 130 mg/dL (milligrams per deciliter) after fasting for at least 8 hours. • Postprandial or after-meal hyperglycemia is defined as a blood sugar usually greater than 180 mg/dL. In people without diabetes postprandial or post-meal sugars rarely go over 140 mg/dL. However, occasionally after a large meal, a 1-2 hour post-meal sugar level can reach 180 mg/dL. Consistently elevated high post-meal blood sugar levels can be an indicator that a person has or is at high risk for developing type 2 diabetes When a person with diabetes has hyperglycemia frequently or for long periods of time as indicated by a high HbA1c blood test, damage to nerves, blood vessels, and other body organs can occur. Hyperglycemia can also lead to more serious conditions, including ketoacidosis -- mostly in people with type 1 diabetes -- and hyperglycemic hyperosmolar nonketotic syndrome (HHNS) in people with type 2 diabetes or in people at risk for type 2 diabetes. It's important to treat hyperglycemia, because if left untreated, hyperglycemia can become severe and lead to serious complications requiring emergency care, such as diabetic coma. In the long term, persistent hyperglycemia, even if not severe can lead to complications affecting your eyes, kidneys, nerves and heart.

Market Analysis:

Hyperglycemia-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Hyperglycemia. This report provides information on the therapeutic development based on the Hyperglycemia dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, IND filed, Preclinical, Discovery and unknown stages, therapeutics assessment by monotherapy and combination products and molecule type drug information.

International symposium and workshops

Advanced Technologies & Treatments for Diabetes, 3–6 February 2016, Italy
World Congress on Interventional Therapies for Type 2 Diabetes & DSS II, 28–30 September 2015, United Kingdom
Diabetes: An Overview, 8 October 2015, London

List of Best International Conferences: